COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 198 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,216 | -15.0% | 162 | +2.5% | 0.00% | – |
Q1 2024 | $6,134 | +280.5% | 158 | +110.7% | 0.00% | – |
Q2 2023 | $1,612 | -20.0% | 75 | -10.7% | 0.00% | – |
Q1 2023 | $2,015 | +15.8% | 84 | +12.0% | 0.00% | – |
Q4 2022 | $1,740 | +74.0% | 75 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 75 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -87.5% | 75 | -80.9% | 0.00% | – |
Q1 2022 | $8,000 | +700.0% | 393 | +1167.7% | 0.00% | – |
Q2 2021 | $1,000 | -97.6% | 31 | -98.7% | 0.00% | – |
Q4 2018 | $42,000 | +16.7% | 2,449 | 0.0% | 0.00% | – |
Q3 2018 | $36,000 | -37.9% | 2,449 | 0.0% | 0.00% | – |
Q2 2018 | $58,000 | -7.9% | 2,449 | 0.0% | 0.00% | – |
Q1 2018 | $63,000 | +40.0% | 2,449 | 0.0% | 0.00% | – |
Q4 2017 | $45,000 | – | 2,449 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |